SIG
NVO

Stanford Investment Group’s Novo Nordisk NVO Stock Holding History

Stanford Investment Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,840
Closed -$33K – 189
2016
Q4 		$33K Hold
1,840
– – 0.02% 182
2016
Q3 		$38K Hold
1,840
– – 0.02% 179
2016
Q2 		$49K Hold
1,840
– – 0.03% 145
2016
Q1 		$50K Hold
1,840
– – 0.03% 139
2015
Q4 		$53K Sell
1,840
-210
-10% -$5.81K 0.03% 126
2015
Q3 		$56K Hold
2,050
– – 0.04% 116
2015
Q2 		$56K Sell
2,050
-300
-13% -$8.43K 0.04% 123
2015
Q1 		$63K Hold
2,350
– – 0.05% 118
2014
Q4 		$50K Buy
+2,350
New +$52.5K 0.04% 136

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Stanford Investment Group's NVO Position: Q1 2017 in Review

Stanford Investment Group sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 1,840 shares — an estimated $33K sold.

Stanford Investment Group first reported a position in NVO in Q4 2014 and held it in 9 quarters. The position peaked at $63K in Q1 2015. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • Stanford Investment Group reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 1,840 Novo Nordisk shares in Q1 2017, an estimated $33K.
  • Stanford Investment Group first reported a position in Novo Nordisk in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Novo Nordisk position peaked at $63K in Q1 2015.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.